Versatile role of curcumin and its derivatives in lung cancer therapy.

Journal of Cellular Physiology
Milad AshrafizadehSaeed Samarghandian

Abstract

Lung cancer is a main cause of death all over the world with a high incidence rate. Metastasis into neighboring and distant tissues as well as resistance of cancer cells to chemotherapy demand novel strategies in lung cancer therapy. Curcumin is a naturally occurring nutraceutical compound derived from Curcuma longa (turmeric) that has great pharmacological effects, such as anti-inflammatory, neuroprotective, and antidiabetic. The excellent antitumor activity of curcumin has led to its extensive application in the treatment of various cancers. In the present review, we describe the antitumor activity of curcumin against lung cancer. Curcumin affects different molecular pathways such as vascular endothelial growth factors, nuclear factor-κB (NF-κB), mammalian target of rapamycin, PI3/Akt, microRNAs, and long noncoding RNAs in treatment of lung cancer. Curcumin also can induce autophagy, apoptosis, and cell cycle arrest to reduce the viability and proliferation of lung cancer cells. Notably, curcumin supplementation sensitizes cancer cells to chemotherapy and enhances chemotherapy-mediated apoptosis. Curcumin can elevate the efficacy of radiotherapy in lung cancer therapy by targeting various signaling pathways, such as epidermal...Continue Reading

References

Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·H MaedaK Hori
Mar 4, 2000·Journal of Pain and Symptom Management·M E Cooley
Apr 21, 2001·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·N KazerouniN Rothman
Oct 27, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·T G SutedjaP E Postmus
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Seiko IshidaIra Herskowitz
Dec 17, 2002·Current Opinion in Hematology·Senitiroh Hakomori
Feb 20, 2004·Glycoconjugate Journal·Meryem Bektas, Sarah Spiegel
May 8, 2004·Trends in Cell Biology·Neil O Carragher, Margaret C Frame
May 26, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Helene PelicanoPeng Huang
Jul 13, 2004·Biochimica Et Biophysica Acta·Michele A WozniakPatricia J Keely
May 12, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anthony J AlbergJonathan M Samet
Dec 27, 2005·Experimental Cell Research·Judah Folkman
Jan 13, 2006·Biochimica Et Biophysica Acta·Bin RenRoya Khosravi-Far
Feb 25, 2006·Respiration; International Review of Thoracic Diseases·Ugo Pastorino
Jun 30, 2006·Nucleic Acids Research·Richard J ShawTriantafillos Liloglou
Jul 29, 2006·Autophagy·Joëlle BottiPatrice Codogno
Aug 8, 2007·Journal of Cellular Physiology·Allison L Berrier, Kenneth M Yamada
Sep 29, 2007·Biochemical Pharmacology·Ajay GoelBharat B Aggarwal
Jan 5, 2008·Cancer Metastasis Reviews·Alessandra GentilePaolo M Comoglio
Sep 3, 2008·Chemical Society Reviews·Ralph A SperlingWolfgang J Parak
Dec 30, 2008·Bioorganic & Medicinal Chemistry Letters·Zhongfa LiuKenneth K Chan
Jan 27, 2009·Cancer Metastasis Reviews·Jihe Zhao, Jun-Lin Guan
Oct 24, 2009·Nature Reviews. Cancer·Hua YuRichard Jove
Dec 8, 2009·Science·Richard O Hynes
Jan 14, 2010·British Journal of Pharmacology·Jaegyu HwangKyoungho Suk
May 12, 2010·Colloids and Surfaces. B, Biointerfaces·Murali Mohan YallapuSubhash C Chauhan
Oct 6, 2010·Advances in Experimental Medicine and Biology·Sandro Sonnino, Alessandro Prinetti
Oct 23, 2010·Nature Reviews. Cancer·William Pao, Juliann Chmielecki
Dec 2, 2010·Advanced Drug Delivery Reviews·Xiaofeng Zhao, Jun-Lin Guan
Aug 13, 2011·Journal of Cancer Research and Clinical Oncology·Bin-Quan WangPing-Chang Yang
Aug 16, 2011·Nanomedicine : Nanotechnology, Biology, and Medicine·Santosh S DhuleRadhika Pochampally
Jun 5, 2012·International Journal of Nanomedicine·Yali WangGuizhen Zhang
Aug 4, 2012·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Maria Manuela GasparCarsten Ehrhardt
Sep 1, 2012·Anti-cancer Agents in Medicinal Chemistry·Vita M Golubovskaya
Sep 5, 2012·International Journal of Cancer. Journal International Du Cancer·Stephen S Hecht
Sep 25, 2012·Cancer Research·Dingcheng GaoVivek Mittal
Nov 22, 2012·Cold Spring Harbor Perspectives in Biology·Jennifer L Stamos, William I Weis
Dec 1, 2012·Archives of Pathology & Laboratory Medicine·Liang GaoStephen T C Wong
Jan 24, 2013·Nature Communications·Jessica BockhornHuiping Liu
Jun 19, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yuan-Yuan LiJames Chung-Man Ho

❮ Previous
Next ❯

Citations

Aug 26, 2020·BMC Cancer·Kamran MansouriShervin Shabani
Mar 28, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Sepideh MirzaeiMasoud Najafi
Apr 25, 2021·Progress in Biophysics and Molecular Biology·Arezoo Gowhari ShabgahJamshid Gholizadeh Navashenaq
Jul 25, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wei-Yang KongLay-Hong Chuah
Jul 24, 2021·Expert Opinion on Drug Discovery·Hidayat HussainSyed Tasadaque Ali Shah
Jul 11, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Sepideh MirzaeiGautam Sethi
Sep 3, 2021·Basic & Clinical Pharmacology & Toxicology·Chong YuMasoud Najafi
Sep 30, 2021·Expert Reviews in Molecular Medicine·Sepideh MirzaeiHaroon Khan
Nov 5, 2020·Recent Patents on Anti-cancer Drug Discovery·Saleh A AlmatroodiArshad Husain Rahmani
Nov 17, 2021·Critical Reviews in Food Science and Nutrition·Mina HomayoonfalBahman Yousefi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms